ClinicalThought

Share

Program Content

Activities

  • FAQs: Refining CLL and SLL Tx
    FAQs: Fine-tuning Contemporary Treatment for Patients With CLL/SLL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 21, 2023

    Expires: July 20, 2024

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

Supporters

Supported by educational grants from AstraZeneca, BeiGene Ltd, and Lilly. Supported by independent educational grants from Merck & Co., Inc., Rahway, NJ, USA, and Pharmacyclics, an AbbVie Company and Janssen Biotech, Inc.

AstraZeneca

BeiGene, Ltd.

Janssen Biotech, Inc.

Lilly

Merck Sharp & Dohme Corp.

Pharmacyclics LLC, an AbbVie Company

Partners

Clinical Care Options, LLC

ProCE Banner